---
category: trading
circular_id: 3a571a22d2fba408
date: '2025-08-01'
description: Settlement calendar for takeover offer of PHARMAIDS PHARMACEUTICALS LIMITED
  scheduled from August 4-18, 2025 with settlement on September 1, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={BC529EBF-3BF0-4983-BED0-F8579D3C456F}&noticeno=20250801-27&dt=08/01/2025&icount=27&totcount=39&flag=0
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Takeover offer with specific settlement procedures affecting trading
  operations for the security
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250801-27&attachedId=
processing:
  attempts: 1
  content_hash: 543055ecc7a5c03e
  processed_at: '2025-08-01T12:46:05.001537'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-01T11:28:31+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={BC529EBF-3BF0-4983-BED0-F8579D3C456F}&noticeno=20250801-27&dt=08/01/2025&icount=27&totcount=39&flag=0
severity: high
source: bse
stocks:
- PHARMAIDS
tags:
- takeover
- settlement
- acquisition
- pharmaids-pharmaceuticals
- otb
- early-pay-in
title: Settlement Schedule Offer to Buy – Acquisition Window (Takeover) for PHARMAIDS
  PHARMACEUTICALS LIMITED
---

## Summary

BSE has announced the settlement schedule for the Offer to Buy – Acquisition Window (Takeover) for PHARMAIDS PHARMACEUTICALS LIMITED. The takeover offer will be conducted from August 4, 2025 to August 18, 2025, with settlement number 2025067 and final settlement date of September 1, 2025.

## Key Points

- Takeover offer period: August 4-18, 2025
- Settlement number: 2025067
- Obligation download date: August 29, 2025
- Settlement date: September 1, 2025
- Demat shares must be delivered through Early Pay-in mechanism
- Market type designation "(Takeover)" required in depository system

## Regulatory Changes

No new regulatory changes introduced. Process follows existing Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange as per Notice No.20200528-32 dated May 28, 2020.

## Compliance Requirements

- Members/Custodians must use Market Type "(Takeover)" and settlement No.2025067 in depository system
- Early pay-in of securities must be completed sufficiently in advance before BSE OTB bidding window closure
- CDSL & NSDL early pay-in securities will be automatically earmarked/blocked in client accounts
- No EPN file upload required for early pay-in
- Members should refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges

## Important Dates

- **August 4, 2025**: Bid start date
- **August 18, 2025**: Bid end date
- **August 29, 2025**: Obligation download date
- **September 1, 2025**: Settlement date

## Impact Assessment

Medium impact on trading operations for PHARMAIDS PHARMACEUTICALS LIMITED. The takeover process requires specific settlement procedures and early pay-in mechanisms. Members and custodians need to ensure compliance with depository requirements and timing deadlines. ICCL Help Desk support available for clarifications during the process.